Delta Infection After Vaccination Elicits Potent Neutralizing Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron

被引:3
|
作者
Zhu, Ka-Li [1 ,2 ]
Gao, Hui-Xia [3 ]
Yao, Lin [2 ]
Rong, Jun [3 ]
Yang, Li [3 ]
Zhang, Zhi [3 ]
Jiang, Ping [3 ]
Duan, Li-Jun [2 ]
Wang, Guo-Lin [2 ]
Dai, Er-Hei [3 ]
Ma, Mai-Juan [1 ,2 ]
机构
[1] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Peoples R China
[2] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, 20 Dongda St, Beijing 100071, Peoples R China
[3] Hebei Med Univ, Hosp Shijiazhuang 5, Shijiazhuang, Hebei, Peoples R China
来源
JOURNAL OF INFECTIOUS DISEASES | 2022年 / 226卷 / 09期
基金
北京市自然科学基金;
关键词
SARS-CoV-2; Delta infection; Omicron; vaccination; neutralization;
D O I
10.1093/infdis/jiac149
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant extensively escape neutralizing antibodies by vaccines or infection. We assessed serum neutralizing activity in sera from Delta infection after vaccination and Delta infection only against SARS-CoV-2 Wuhan-Hu-1 (WA1), Beta, Delta, and Omicron. Sera from Delta infection only could neutralize WA1 and Delta but almost completely lost capacity to neutralize Beta and Omicron. However, Delta infection after vaccination resulted in a significant increase of serum neutralizing activity against WA1, Beta, and Omicron. This study demonstrates that breakthrough infection of Delta substantially induced high potency humoral immune response against the Omicron variant and other emerged variants. The sera from patients with the Delta infection only had less neutralizing activity to the Omicron, whereas the sera from patients with Delta infection after vaccination displayed potent neutralization to the Omicron variant.
引用
收藏
页码:1551 / 1555
页数:5
相关论文
共 50 条
  • [21] Lower Risk of Multisystem Inflammatory Syndrome in Children With the Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2
    Cohen, Jonathan M.
    Carter, Michael J.
    Cheung, C. Ronny
    Ladhani, Shamez
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E518 - E521
  • [22] Protection Against the Omicron Variant Offered by Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Retrospective Cohort Study
    Rothberg, Michael B.
    Kim, Priscilla
    Shrestha, Nabin K.
    Kojima, Lisa
    Tereshchenko, Larisa G.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E142 - E147
  • [23] Outcomes of wuhan, alpha, delta, omicron and other variants in severe acute respiratory syndrome coronavirus-2
    Bayrakci, Onur
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2023, 61 (08) : 646 - 653
  • [24] Description of Hospitalizations due to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Based on Vaccination Status
    Moffa, Matthew A.
    Shively, Nathan R.
    Carr, Dustin R.
    Bremmer, Derek N.
    Buchanan, Carley
    Trienski, Tamara L.
    Jacobs, Max W.
    Saini, Vikram
    Walsh, Thomas L.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (09):
  • [25] Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Natural Immunity and Protection Against the Delta Variant: A Retrospective Cohort Study
    Kim, Priscilla
    Gordon, Steven M.
    Sheehan, Megan M.
    Rothberg, Michael B.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E185 - E190
  • [26] Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection
    Nie, YC
    Wang, GW
    Shi, XL
    Zhang, H
    Qiu, Y
    He, ZP
    Wang, W
    Lian, GW
    Yin, XL
    Du, LY
    Ren, LL
    Wang, JW
    He, X
    Li, TS
    Deng, HK
    Ding, MX
    JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (06): : 1119 - 1126
  • [27] Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    Lin, Dan-Yu
    Gu, Yu
    Zeng, Donglin
    Janes, Holly E.
    Gilbert, Peter B.
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (03) : 544 - 552
  • [28] Respiratory management in severe acute respiratory syndrome coronavirus 2 infection
    Price, Susanna
    Singh, Suveer
    Ledot, Stephane
    Bianchi, Paolo
    Hind, Matthew
    Tavazzi, Guido
    Vranckx, Pascal
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2020, 9 (03) : 229 - 238
  • [29] Generalized erythrodermic psoriasis triggered by vaccination against severe acute respiratory syndrome Coronavirus 2
    Tong Ba Tran
    Nhi Thi Uyen Pham
    Huy Ngoc Phan
    Hao Trong Nguyen
    DERMATOLOGIC THERAPY, 2022, 35 (06)
  • [30] Intussusception in the setting of severe acute respiratory syndrome coronavirus 2 infection following rotavirus vaccination
    Swyden, Shelbi
    Damanakis, Haralambos
    Cooper, Arthur
    Velasquez, James
    James, Jamila
    JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2022, 3 (02)